The Phase I clinical study, in which the new Alzheimer's drug candidate PRI-002 is being tested for the first time in humans, has now officially…
Together with Japanese colleagues, biophysicists at Heinrich Heine University Düsseldorf (HHU) and Jülich Research Centre have examined the folding of…
On September 21, the international World Alzheimer’s Day, Prof. Willbold has given an interview to the Biophysical Society on how biophysics research…
A team of researchers from Germany and the Netherlands have determined the structure of an amyloid fibril with previously unachieved resolution. The…
We are pleased to invite you to the second Düsseldorf-Jülich Symposium on Neurodegenerative Diseases "Formation, aggregation and propagation of…
Jun.-Prof. Dr. Alexander Büll (34) has been awarded the Erwin Niehaus-Preis by the Alzheimer Forschung Initiative e.V. (AFI). With the award comes…
Researchers from Jülich and Düsseldorf have succeeded in taking an important step towards making LOV proteins more usable for future biotechnological…
New drugs to treat Alzheimer’s disease are urgently needed. One approach might be to prevent the clustering of molecules of the amyloid beta protein,…
Dr. Wolfgang Hoyer is the recipient of one of the prestigious Consolidator Grants of the European Research Council ERC. For his project "BETACONTROL"…
This year’s Nobel Prize in Physiology or Medicine will be awarded on 10 December in Stockholm in recognition of research on the molecular principles…
